diaziquone has been researched along with Ependymoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, JS; Khan, AH | 1 |
| Bjornsson, TD; Falletta, JM; Friedman, HS; Schold, SC | 1 |
2 other study(ies) available for diaziquone and Ependymoma
| Article | Year |
|---|---|
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
Topics: Animals; Antineoplastic Agents; Aziridines; Brain Neoplasms; Central Nervous System; Ependymoma; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Quinones | 1976 |
Treatment of patients with recurrent primary brain tumors with AZQ.
Topics: Adolescent; Adult; Aged; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Ependymoma; Female; Glioma; Humans; Male; Medulloblastoma; Middle Aged | 1984 |